Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Energy Transfer (ET) offers a compelling entry: buy units at $21.17 for a roughly 6.4% yield on cost, backed by raised 2026 guidance, expanding infrastructure exposure to AI data centers and LNG exports, and an 8.2x EV/EBITDA valuation. Target $24.50 over the next 180 trading days while protecting capital with a $19.00 stop.
Bank of America identified cybersecurity vendors it believes are best positioned to benefit as artificial intelligence alters both attacker tactics and defensive requirements within enterprise environments. The firm emphasized vendors that address risks stemming from machine identities, cloud workloads and AI-native threats, assigning Buy ratings t…
Arista posted a $3.036B Q2 and raised guidance to $12.6B, validating its AI networking momentum. Strong margins, $5.16B in free cash flow and zero debt underpin a thesis for multiple expansion. Initiate a long with a $186.46 entry, $240 target and $160 stop for a long-term (180 trading days) trade.
European wholesale gas prices rose modestly as continued disruptions to tanker transit through the Strait of Hormuz and a shortfall in underground storage outweighed a temporary easing in global yields. Traders saw Dutch futures hold above multi-month support while U.K. contracts strengthened amid concerns about near-term supply into North Sea hubs…
Infosys is trading near its recent lows after a sharp re-rating, but fundamentals and strategic M&A suggest the market has overshot. At $12.03 the stock offers a 3.8% yield, a P/E around 14.5, and an attractive market-cap base of $48.8B. We recommend a disciplined long with a defined entry at $12.00, stop at $10.25 and target of $16.50 over a swing…
Attacks on grain infrastructure in the Black Sea have disrupted shipments during the height of the export season, prompting major wheat importers to scramble for replacement supplies. Physical prices in Australia, Argentina and the United States have risen as benchmark Chicago futures climbed more than 17% since early July. Buyers in Asia, the Midd…
Seabridge Gold is a development-stage gold company with sizable long-life projects and a capital structure that can deliver big upside if permitting, financing or a major partner materializes. The stock looks fairly priced for the base case but offers an attractive asymmetric payoff if catalysts hit. This trade idea lays out a concrete entry, prote…
Odysight.ai Inc. announced the pricing of an $11 million public offering of 3,437,500 common shares at $3.20 per share. The proceeds will fund research and development, sales and marketing to scale commercial operations, and general corporate purposes. The offering includes participation from company insiders and is managed by Roth Capital Partners…
Bitcoin led a broad crypto rally on Thursday, climbing nearly 8% to trade just under $70,000 after U.S. President Donald Trump urged Congress to approve the Clarity act. The move coincided with improved risk appetite following the U.S. Treasury’s decision to double the size of debt buyback operations, which helped push yields lower. Major altcoins …
Kid ASA reported second-quarter revenue of NOK 914.80 million, beating analyst expectations of NOK 904 million and marking a 6.8% year-over-year increase. The Norway-based home goods retailer expanded gross margin to 63.2% and delivered EBITDA of NOK 217.80 million, while earnings per share rose to NOK 0.90. Management did not provide future guidan…
Hanmi Financial (HAFC) is showing steady earnings power, a conservative balance sheet and active capital returns. At roughly $31.15, the shares look positioned for a mid-term re-rating supported by continued buybacks, a raised dividend and low leverage. This trade idea lays out entry, target and stop along with the catalysts and risks that will det…
Trevi Therapeutics (TRVI) is a clinical-stage biotech advancing Haduvio (oral nalbuphine ER) for chronic cough and pruritic conditions. Recent financing and conference activity have tightened the runway and investor attention; valuation is rich given development-stage fundamentals, but positive cough data and heavy short interest create a tacticall…
ServiceNow is positioned to report another AI-accelerated quarter. With a $29B backlog, $4.6B in free cash flow and improving technical momentum, the pieces point to a Q3 beat. This is a tactical swing long: enter at market, limit risk with a $115 stop, target $150 as investors re-rate durable AI workflow monetization.
Frontline plc (FRO) looks expensive to some screens - price near a 52-week high and elevated PB - but dividend yield (7.2%), improving tanker fundamentals and bullish momentum create a compelling mid-term trade. Entry $44.43, stop $39.00, target $52.00; mid-term (45 trading days) outlook.
Meta's shares have retraced sharply from last year's peak as a major child safety trial and broader market risk-off sentiment weigh on the name. At $550 today, the company still generates robust free cash flow ($40.98B) and trades at ~20x earnings, leaving room for upside if ad demand stabilizes and litigation proves containable. This note lays out…
PayPal’s board rejected a $60.50-per-share joint offer from Stripe and Advent International. With a $52B+ market cap, strong free cash flow and a low multiple profile, PayPal is an attractive takeover target that could prompt a renewed bid above the current $61 area. This note lays out an actionable trade: enter at $61.35, target $70.00, stop $58.0…
SK hynix sits at the intersection of secular AI memory demand and a highly consolidated supply base. For disciplined traders willing to tolerate memory cyclicality, a controlled long-term long can capture significant upside if industry economics and M&A dynamics accelerate.
Himax (HIMX) is a small-cap semiconductor specialist that quietly supplies display drivers, wafer-level optics and LCoS microdisplays into automotive and AR chains. The business combines in-house manufacturing, steady cash return via dividends, and recent product ramps (OLED touch controllers, Front-lit LCoS) that justify a tactical long. We lay ou…
Edesa Biotech, a clinical-stage biopharmaceutical company listed on Nasdaq, announced the pricing of an underwritten public offering expected to raise gross proceeds of approximately $25 million. The offering includes common shares and warrants, aimed at supporting general corporate purposes including working capital, capital expenditures, and adva…
Teradyne is benefiting from an AI-led memory and semiconductor cycle that is pushing test volume and complexity higher. Strong Q2 results and bullish guidance justify an upgraded buy, but near-term volatility and stretched multiples argue for a dip-entry approach. Trade plan included for a mid-term swing with clear entry, stop and target.
Elanco's recent quarterly beat, new emergency-use approvals, and continued pet-care tailwinds create a practical long trade with clearly defined entry, stop and target. The company trades at roughly $12.2B market cap, generates positive free cash flow, and carries moderate leverage - a setup where execution on product launches will control the next…
UiPath has moved from growth skepticism to hitting profitability, raising guidance and showing early success with agentic AI orchestration. With a market cap near $8.2B, attractive cash flow, improving margins and heavy short positioning, the risk/reward favors a tactical long over the next 45 trading days if ARR and execution continue to validate …
Oil prices were largely unchanged in early trade as investors weighed the risk of a wider U.S.-Iran conflict and ongoing uncertainty about shipping through the Strait of Hormuz. Brent rose slightly, U.S. WTI contracts moved unevenly, and U.S. stockpile data showed a larger-than-expected crude build alongside shifts in refined product inventories.
Telix Pharmaceuticals announced a 22% year-over-year revenue increase to $477 million in H1 2026, supported by strong sales growth in its precision medicine segment. The company achieved margin improvements and a 146% rise in adjusted EBITDA to $52 million, bolstered by a $40 million upfront payment from a strategic collaboration with Regeneron. Si…
The U.S. Education Department's office for civil rights has released guidance instructing schools that changing discipline policies with the specific aim of reducing racial disparities amounts to race discrimination. The guidance labels practices described as "racial balancing" as discriminatory and follows the department's removal last month of se…
